ALDOSTERONISM
Prepared by: Roxanne Mae E. Birador S.N.
LAYERS OF ADRENAL CORTEX
ALDOSTERONE
Conserve sodium in the body. It promotes
reabsorption of sodium and elimination of
potassium.
ALDOSTERONISM
excessive secretion of aldosterone
(Hyporeninemic Hyperaldosteronism)
Over activity of both adrenal glands
A malignant growth of the outer layer (cortex) of the
adrenal gland (adrenal cortical cancer)
(A) Aldosterone producing adenoma;
(B) Micronodular diffuse hyperplasia.
Excessive thirst (polydipsia)
Increased urination
(polyuria)
Hypokalemia
Hypernatremia
Muscle weakness
Fatigue
Hypertension
• PAC:PRA ratio
The first test used in patients
suspected to have primary
hyperaldosteronism measures the
Plasma Aldosterone Concentration
(PAC) to Plasma Renin Activity (PRA)
Ratio.
A high ratio of PAC to PRA
suggests primary hyperaldosteronism.
Captopril Suppression Test
Captopril is a medication for high blood
pressure. A patient is given a single dose of captopril,
after which the levels of aldosterone and renin in the
blood are measured.
In patients with primary hyperaldosteronism, the
level of aldosterone in the blood is still high and the
level of renin is low even after captopril administration.
24-Hour Urinary Excretion of
Aldosterone Test
In the 24-hour urinary excretion of
aldosterone test, a patient eats a high-salt
diet for 5 days before measuring the
amount of aldosterone in the urine over a
24-hour period.
In patients with primary
hyperaldosteronism, aldosterone will not be
suppressed by the salt load, and the level of
aldosterone in the urine will be high.
Saline Suppression Test:
In the saline suppression test, the patient is
given a salt solution through an IV, after which the
levels of aldosterone and renin in the blood are
measured.
In patients with primary hyperaldosteronism, the
level of aldosterone in the blood is still high and the
level of renin is low even after this salt loading.
CT scan showing right adrenal adenoma
Aldosterone-blocking drugs
(mineralocorticoid receptor
antagonists): DIURETICS
Eplerenone (Inspra)
Spironolactone (Aldactone)
• Give daily doses early so that
increased urination does not
interfere with sleep.
• Measure and record regular weight
to monitor mobilization of edema
fluid.
• Avoid giving food rich in potassium.
• Review electrolyte levels.
Amlodipine (Norvasc)
Diltiazem (Cardizem, Tiazac)
Felodipine
Isradipine
Nicardipine (Cardene SR)
Nifedipine (Procardia)
Nisoldipine (Sular)
Verapamil (Calan, Verelan)
• Take medication
with food or milk.
• Alcohol should be
avoided.
Accupril (quinapril)
Aceon (perindopril)
Altace (ramipril)
Capoten (captopril)
Lotensin (benazepril)
Mavik (trandolapril)
Monopril (fosinopril)
Prinivil, Zestril (lisinopril)
• Monitor blood pressure and pulse frequently
during initial dose adjustment and
periodically during therapy.
• The drug should be administered 1 hour
before or 2 hours after meals. It may be
crushed if the patient has difficulty
swallowing.
Example: K-Lyte
• Take this medication with food or just after
a meal.
• Avoid lying down for at least 30 minutes
after you take this medication.
Adrenalectomy a surgical removal of adrenal glands.
Advise to low salt diet contains less
than 1,500 mg (1.5 grams) of salt per
day. One teaspoon of salt contains
about 2,300 mg of sodium.
Avoid cooking with salt.
Avoid fast food.
Avoid salty foods.
Avoid seasonings that
contain sodium.
Promote exercise, achieve
healthy weight.
Advise smoke cessation.
Avoid alcohol and limit
caffeine.
Altered fluid and electrolyte balance
Fluid volume excess related to sodium and water
retention associated with an increased aldosterone level
resulting from activation of the renin-angiotensin-
aldosterone mechanism as a result of decreased renal
blood flow (occurs because of a decrease in intravascular
volume that results from vasodilation and from third-spacing
and sequestration of fluid in the splanchnic system)
Decreased cardiac output related to
vasoconstriction
Knowledge deficit related to lack of
information about the disease
process and self-care
References:
Gordon RD, Stowasser M, Klemm SA, Tunny TJ. Primary aldosteronism and
other forms of mineralocorticoid hypertension. In: Swales JD (ed) Textbook of
Hypertension. Blackwells Science, Oxford. 1994:865-892.Kem DC, Weinberger
M, Gomez-Sanchez C, Kramer NJ, Lerman R, Furuyama S, Nugent CA. Circadian
rhythm of plasma aldosterone concentration in patients with primary
aldosteronism. J Clin Invest 1973;52:2272-2277
Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L,
Marafetti L, Veglio F, Maccario M. Comparison of confirmatory tests for the
diagnosis of primary aldosteronism. J Clin Endocrinol Metab 2006;91:2618-
2623.Streeten DH, Tomycz N, Anderson GH. Reliability of screening methods
for the diagnosis of primary hyperaldosteronism. Am J Med 1979;67:403-413.
Retrieved (July 18, 2015) from:
http://www.pathology.leedsth.nhs.uk/dnn_bilm/Investigationprotocols/Hyper
aldosteronismprotocols/FludrocortisoneSuppressionTestforHyperaldoster.aspx
Marilynn E. Doenges., Mary Frances Moorhouse., Alice C. Murr., Nurse’s
Pocket Guide., Edition 13th., Diagnoses.
Diseases and Conditions., January 04, 2014., Primary Aldosteronism.
Retrieved (July 18, 2015) from: http://www.mayoclinic.org/diseases-
conditions/primary-aldosteronism/basics/symptoms/con-20030194
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott
Gettings, MD
Copyright 1989-2015 DSHI Systems., Nov 1, 2010.,
Hyperaldosteronism. Retrieved (July 18, 2015) from
http://www.freemd.com/hyperaldosteronism/anatomy.htm
Ashley B. Grossman, MD, FRCP, FMedSci., Aldosteronism., Professional
vison. Retrieved (July 18, 2015) from:
http://www.msdmanuals.com/professional/endocrine-and-metabolic-
disorders/adrenal-disorders/secondary-aldosteronism
Nicholas J Sarlis, MD, PhD, FACP Vice President, Head of Medical
Affairs, Incyte Corporation., Primary Aldosteronism., News and
Perspective. Retrieved (July 18, 2015) from:
http://emedicine.medscape.com/article/127080-overview#a4
ALDOSTERONISM

ALDOSTERONISM

  • 1.
  • 2.
  • 3.
    ALDOSTERONE Conserve sodium inthe body. It promotes reabsorption of sodium and elimination of potassium. ALDOSTERONISM excessive secretion of aldosterone
  • 4.
    (Hyporeninemic Hyperaldosteronism) Over activityof both adrenal glands A malignant growth of the outer layer (cortex) of the adrenal gland (adrenal cortical cancer)
  • 5.
    (A) Aldosterone producingadenoma; (B) Micronodular diffuse hyperplasia.
  • 6.
    Excessive thirst (polydipsia) Increasedurination (polyuria) Hypokalemia Hypernatremia Muscle weakness Fatigue Hypertension
  • 8.
    • PAC:PRA ratio Thefirst test used in patients suspected to have primary hyperaldosteronism measures the Plasma Aldosterone Concentration (PAC) to Plasma Renin Activity (PRA) Ratio. A high ratio of PAC to PRA suggests primary hyperaldosteronism.
  • 9.
    Captopril Suppression Test Captoprilis a medication for high blood pressure. A patient is given a single dose of captopril, after which the levels of aldosterone and renin in the blood are measured. In patients with primary hyperaldosteronism, the level of aldosterone in the blood is still high and the level of renin is low even after captopril administration.
  • 10.
    24-Hour Urinary Excretionof Aldosterone Test In the 24-hour urinary excretion of aldosterone test, a patient eats a high-salt diet for 5 days before measuring the amount of aldosterone in the urine over a 24-hour period. In patients with primary hyperaldosteronism, aldosterone will not be suppressed by the salt load, and the level of aldosterone in the urine will be high. Saline Suppression Test: In the saline suppression test, the patient is given a salt solution through an IV, after which the levels of aldosterone and renin in the blood are measured. In patients with primary hyperaldosteronism, the level of aldosterone in the blood is still high and the level of renin is low even after this salt loading.
  • 11.
    CT scan showingright adrenal adenoma
  • 12.
    Aldosterone-blocking drugs (mineralocorticoid receptor antagonists):DIURETICS Eplerenone (Inspra) Spironolactone (Aldactone)
  • 13.
    • Give dailydoses early so that increased urination does not interfere with sleep. • Measure and record regular weight to monitor mobilization of edema fluid. • Avoid giving food rich in potassium. • Review electrolyte levels.
  • 14.
    Amlodipine (Norvasc) Diltiazem (Cardizem,Tiazac) Felodipine Isradipine Nicardipine (Cardene SR) Nifedipine (Procardia) Nisoldipine (Sular) Verapamil (Calan, Verelan)
  • 15.
    • Take medication withfood or milk. • Alcohol should be avoided.
  • 16.
    Accupril (quinapril) Aceon (perindopril) Altace(ramipril) Capoten (captopril) Lotensin (benazepril) Mavik (trandolapril) Monopril (fosinopril) Prinivil, Zestril (lisinopril)
  • 17.
    • Monitor bloodpressure and pulse frequently during initial dose adjustment and periodically during therapy. • The drug should be administered 1 hour before or 2 hours after meals. It may be crushed if the patient has difficulty swallowing.
  • 18.
    Example: K-Lyte • Takethis medication with food or just after a meal. • Avoid lying down for at least 30 minutes after you take this medication.
  • 19.
    Adrenalectomy a surgicalremoval of adrenal glands.
  • 20.
    Advise to lowsalt diet contains less than 1,500 mg (1.5 grams) of salt per day. One teaspoon of salt contains about 2,300 mg of sodium. Avoid cooking with salt. Avoid fast food. Avoid salty foods.
  • 21.
    Avoid seasonings that containsodium. Promote exercise, achieve healthy weight. Advise smoke cessation. Avoid alcohol and limit caffeine.
  • 22.
    Altered fluid andelectrolyte balance Fluid volume excess related to sodium and water retention associated with an increased aldosterone level resulting from activation of the renin-angiotensin- aldosterone mechanism as a result of decreased renal blood flow (occurs because of a decrease in intravascular volume that results from vasodilation and from third-spacing and sequestration of fluid in the splanchnic system)
  • 23.
    Decreased cardiac outputrelated to vasoconstriction Knowledge deficit related to lack of information about the disease process and self-care
  • 24.
    References: Gordon RD, StowasserM, Klemm SA, Tunny TJ. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Swales JD (ed) Textbook of Hypertension. Blackwells Science, Oxford. 1994:865-892.Kem DC, Weinberger M, Gomez-Sanchez C, Kramer NJ, Lerman R, Furuyama S, Nugent CA. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. J Clin Invest 1973;52:2272-2277 Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F, Maccario M. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab 2006;91:2618- 2623.Streeten DH, Tomycz N, Anderson GH. Reliability of screening methods for the diagnosis of primary hyperaldosteronism. Am J Med 1979;67:403-413. Retrieved (July 18, 2015) from: http://www.pathology.leedsth.nhs.uk/dnn_bilm/Investigationprotocols/Hyper aldosteronismprotocols/FludrocortisoneSuppressionTestforHyperaldoster.aspx Marilynn E. Doenges., Mary Frances Moorhouse., Alice C. Murr., Nurse’s Pocket Guide., Edition 13th., Diagnoses.
  • 25.
    Diseases and Conditions.,January 04, 2014., Primary Aldosteronism. Retrieved (July 18, 2015) from: http://www.mayoclinic.org/diseases- conditions/primary-aldosteronism/basics/symptoms/con-20030194 Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD Copyright 1989-2015 DSHI Systems., Nov 1, 2010., Hyperaldosteronism. Retrieved (July 18, 2015) from http://www.freemd.com/hyperaldosteronism/anatomy.htm Ashley B. Grossman, MD, FRCP, FMedSci., Aldosteronism., Professional vison. Retrieved (July 18, 2015) from: http://www.msdmanuals.com/professional/endocrine-and-metabolic- disorders/adrenal-disorders/secondary-aldosteronism Nicholas J Sarlis, MD, PhD, FACP Vice President, Head of Medical Affairs, Incyte Corporation., Primary Aldosteronism., News and Perspective. Retrieved (July 18, 2015) from: http://emedicine.medscape.com/article/127080-overview#a4